Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PREMARIN® Index Section (conjugated estrogens)

FULL PRESCRIBING INFORMATION: CONTENTS*

WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER AND PROBABLE DEMENTIA

1 INDICATIONS AND USAGE

1.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause

1.2 Treatment of Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy due to Menopause

1.3 Treatment of Hypoestrogenism due to Hypogonadism, Castration or Primary Ovarian Failure

1.4 Treatment of Breast Cancer (for Palliation Only) in Appropriately Selected Women and Men with Metastatic Disease

1.5 Treatment of Advanced Androgen-Dependent Carcinoma of the Prostate (for Palliation Only)

1.6 Prevention of Postmenopausal Osteoporosis

2 DOSAGE AND ADMINISTRATION

2.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause

2.2 Treatment of Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy due to Menopause

2.3 Treatment of Hypoestrogenism due to Hypogonadism, Castration, or Primary Ovarian Failure

2.4 Treatment of Breast Cancer (for Palliation Only) in Appropriately Selected Women and Men with Metastatic Disease

2.5 Treatment of Advanced Androgen-Dependent Carcinoma of the Prostate (for Palliation Only)

2.6 Prevention of Postmenopausal Osteoporosis

3 DOSAGE FORMS AND STRENGTHS

4 CONTRAINDICATIONS

5 WARNINGS AND PRECAUTIONS

5.1 Cardiovascular Disorders

5.2 Malignant Neoplasms

5.3 Probable Dementia

5.4 Gallbladder Disease

5.5 Hypercalcemia

5.6 Visual Abnormalities

5.7 Anaphylactic Reaction and Angioedema

5.8 Addition of a Progestin When a Woman Has Not Had a Hysterectomy

5.9 Elevated Blood Pressure

5.10 Hypertriglyceridemia

5.11 Hepatic Impairment and/or Past History of Cholestatic Jaundice

5.12 Hypothyroidism

5.13 Fluid Retention

5.14 Hypocalcemia

5.15 Hereditary Angioedema

5.16 Exacerbation of Endometriosis

5.17 Exacerbation of Other Conditions

5.18 Laboratory Tests

5.19 Drug-Laboratory Test Interactions

6 ADVERSE REACTIONS

6.1 Clinical Study Experience

6.2 Postmarketing Experience

7 DRUG INTERACTIONS

7.1 Metabolic Interactions

8 USE IN SPECIFIC POPULATIONS

8.1 Pregnancy

8.3 Nursing Mothers

8.4 Pediatric Use

8.5 Geriatric Use

8.6 Renal Impairment

8.7 Hepatic Impairment

10 OVERDOSAGE

11 DESCRIPTION

12 CLINICAL PHARMACOLOGY

12.1 Mechanism of Action

12.2 Pharmacodynamics

12.3 Pharmacokinetics

13 NONCLINICAL TOXICOLOGY

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

14 CLINICAL STUDIES

14.1 Effects on Vasomotor Symptoms

14.2 Effects on Vulvar and Vaginal Atrophy

14.3 Effects on Bone Mineral Density

14.4 Effects on Female Hypogonadism

14.5 Women's Health Initiative Studies

14.6 Women's Health Initiative Memory Study

15 REFERENCES

16 HOW SUPPLIED/STORAGE AND HANDLING

16.1 How Supplied

16.2 Storage and Handling

17 PATIENT COUNSELING INFORMATION

17.1 Vaginal Bleeding

17.2 Possible Serious Adverse Reactions With Estrogens

17.3 Possible Less Serious But Common Adverse Reactions With Estrogens

WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT PREMARIN (AN ESTROGEN MIXTURE)?

*
Sections or subsections omitted from the full prescribing information are not listed.
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event